BLEOMYCINE HIKMA 15 mg, poudre pour solution injectable — 1 flacon(s) en verre de 15 mg

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930131961
  • CIP7 3013196
  • CIS 62789360

What the source publishes

Holder
HIKMA FRANCE
Active ingredients
SULFATE DE BLÉOMYCINE, BLÉOMYCINE
Form
poudre pour solution injectable
Package
1 flacon(s) en verre de 15 mg
Routes
intramusculaire, intraveineuse, sous-cutanée
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
1997-12-04
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930131961
{
  "cis": "62789360",
  "cip7": "3013196",
  "form": "poudre pour solution injectable",
  "name": "BLEOMYCINE HIKMA 15 mg, poudre pour solution injectable — 1 flacon(s) en verre de 15  mg",
  "cip13": "3400930131961",
  "holder": "HIKMA FRANCE",
  "routes": [
    "intramusculaire",
    "intraveineuse",
    "sous-cutanée"
  ],
  "holders": [
    "HIKMA FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "40.26",
  "authorisedOn": "1997-12-04",
  "compositions": [
    {
      "name": "SULFATE DE BLÉOMYCINE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "02952",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "BLÉOMYCINE",
      "nature": "FT",
      "strength": "15 mg",
      "linkageNumber": "1",
      "substanceCode": "55004",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "39.24",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "BLEOMYCINE HIKMA 15 mg, poudre pour solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon(s) en verre de 15  mg",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "1970-01-19",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SULFATE DE BLÉOMYCINE",
    "BLÉOMYCINE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930131961"